You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

IL-17 predicts the effect of TACE combined with apatinib in hepatocellular carcinoma

Price: EUR 27.50